Geode Capital Management
ANRO icon

Geode Capital Management’s Alto Neuroscience ANRO Stock Holding History

Geode Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Buy
678,199
+385,300
+132% +$8.91M ﹤0.01% 2215
2026
Q1 		$6.59M Buy
292,899
+5,464
+2% +$101K ﹤0.01% 2609
2025
Q4 		$5.12M Buy
287,435
+49,535
+21% +$624K ﹤0.01% 2754
2025
Q3 		$957K Buy
237,900
+8,179
+4% +$27.1K ﹤0.01% 3395
2025
Q2 		$506K Sell
229,721
-257,138
-53% -$612K ﹤0.01% 3549
2025
Q1 		$1.05M Buy
486,859
+14,202
+3% +$50.8K ﹤0.01% 3293
2024
Q4 		$2M Buy
472,657
+2,669
+0.6% +$16.7K ﹤0.01% 3124
2024
Q3 		$5.38M Buy
469,988
+281,018
+149% +$3.44M ﹤0.01% 2722
2024
Q2 		$2.02M Buy
188,970
+102,829
+119% +$1.34M ﹤0.01% 3128
2024
Q1 		$1.32M Buy
+86,141
New +$1.35M ﹤0.01% 3257

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management's ANRO Position: Q2 2026 in Review

Geode Capital Management increased its Alto Neuroscience (ANRO) stake by 132% in Q2 2026, buying an estimated $8.91M and bringing the position to 678,199 shares worth $17.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

Geode Capital Management first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Geode Capital Management held 678,199 shares of Alto Neuroscience worth $17.9M as of Q2 2026.
  • Geode Capital Management bought 385,300 Alto Neuroscience shares in Q2 2026, an estimated $8.91M.
  • Alto Neuroscience made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2215 holding.
  • Geode Capital Management first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.